---
title: "New regulations for national HIV drug resistance research released, Aidea Pharma deeply involved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247408838.md"
description: "Aidea Pharma participated in the \"Guidelines for Clinical Drug Resistance Research and Data Submission for Anti-HIV Infection\" released by the National Medical Products Administration, providing regulatory support for the research and development of anti-HIV drugs. The company was invited to attend a relevant expert consultation meeting in September 2024, demonstrating its leadership position in the domestic anti-HIV research and development field"
datetime: "2025-07-06T12:38:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247408838.md)
  - [en](https://longbridge.com/en/news/247408838.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247408838.md)
generator: "portal-rs"
---

# New regulations for national HIV drug resistance research released, Aidea Pharma deeply involved

On July 6th, Aidea Pharma announced that the National Medical Products Administration's Drug Evaluation Center has released the "Guidelines for Clinical Resistance Studies and Data Submission for Anti-HIV Infection Drugs," laying a solid regulatory foundation for the development of anti-HIV drugs. Notably, as early as September 2024, Aidea Pharma, as a leader in domestic anti-HIV drug development, was invited to participate in the expert consultation meeting for the draft of these guidelines and was deeply involved in the process

### Related Stocks

- [688488.CN](https://longbridge.com/en/quote/688488.CN.md)

## Related News & Research

- [Why are bond yields surging, and why does it matter?](https://longbridge.com/en/news/296320283.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [REG - Gooch & Housego PLC Odyssean Inv. Trust - Holding(s) in Company](https://longbridge.com/en/news/296616769.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**